Our team within the Division of Blood and Marrow Transplantation is focused on the integral relationship between clinical care and research. We continue to break new ground in a variety of areas. We are leaders in alternative stem cell therapies, umbilical cord blood transplantation and immune-based therapies. We also provide novel treatment options for patients with rare, life-threating conditions and work tirelessly to reduce transplant side effects and improve quality of life for patients after transplant.
Researchers in the Transplant Biology and Therapy program collaborate closely with scientists from the University of Minnesota's Masonic Cancer Center, Stem Cell Institute and Medical School to further knowledge of using blood and marrow transplantation for treating cancer and other diseases. This groundbreaking research has led to the development of treatments for leukemia, lymphoma, inherited genetic diseases, immune disorders and hemoglobinopathies.